The Sabin-Aspen Vaccine Science & Policy Group

The Sabin-Aspen Vaccine Science & Policy Group brings together senior leaders across many disciplines to examine some of the most challenging vaccine-related issues and drive impactful change. Members are influential, creative, out-of-the-box thinkers who vigorously probe a single topic each year and develop actionable recommendations to advance innovative ideas for the development, distribution, and use of vaccines, as well as evidence based and cost-effective approaches to immunization. The Group’s latest report “Powering Vaccine R&D: Opportunities for Transformation,” takes a look at all the core components of the vaccine ecosystem and finds opportunities to transform and accelerate the development of vaccines.  The Group’s 2020 Report “Meeting the Challenge of Vaccination Hesitancy,” calls for an urgent, coordinated effort to strengthen vaccine acceptance and address the risk that vaccination hesitancy – the reluctance or opposition to vaccination despite the availability of safe and effective vaccines – poses to communities around the world. The group’s recommendations on how to overcome the scientific, financial and organizational barriers to developing a vaccine are synthesized in the report Accelerating the Development of a Universal Influenza Vaccine,” published in July 2019.